Bluesky Facebook Reddit Email

NIH grantees find metabolic pathway in malaria parasites; possible drug targets

08.04.10 | NIH/National Institute of Allergy and Infectious Diseases

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

In most living things, several major chemical processes involved in converting food to energy are linked through a cyclic hub called the tricarboxylic acid cycle, also known as the Krebs cycle. NIAID grantee Manuel Llinás, Ph.D., of Princeton University, and his colleagues discovered that Plasmodium falciparum, the deadliest malaria parasite, uses a double-branched metabolic pathway instead of the classical loop. According to Dr. Llinás, this specific branched pathway has not been detected previously in any other organism.

The malaria parasite appears to use one branch primarily to generate the molecule acetyl-CoA, which it needs to thrive within a host organism. This branch may represent particularly vulnerable spots to target with anti-malarial drugs, says Dr. Llinás. The detailed description of the chemical steps involved in the metabolic pathway of the malaria parasite also could aid future malaria drug development efforts because the pathway sits at the heart of several other biological processes currently being investigated as drug targets.

So far, it is clear that the newly discovered pathway operates while the parasites are growing inside human blood cells. Next, the scientists will explore whether the parasite uses the same pathway during other stages of its lifecycle in humans and in mosquitoes, and how exactly it is involved in the metabolic control of the cell.

KL Olszewski et al. Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature . DOI: 10.1038/nature09301 (2010).

M. John Rogers, Ph.D., Preclinical Parasite Drug Development Program Officer, NIAID, is available to discuss this research.

To schedule interviews, please contact the NIAID Office of Communications, 301-402-1663, niaidnews@niaid.nih.gov .

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov .

The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov .

Nature

Keywords

Article Information

Contact Information

NIAID Office of Communications
NIH/National Institute of Allergy and Infectious Diseases
niaidnews@niaid.nih.gov

How to Cite This Article

APA:
NIH/National Institute of Allergy and Infectious Diseases. (2010, August 4). NIH grantees find metabolic pathway in malaria parasites; possible drug targets. Brightsurf News. https://www.brightsurf.com/news/L5579QXL/nih-grantees-find-metabolic-pathway-in-malaria-parasites-possible-drug-targets.html
MLA:
"NIH grantees find metabolic pathway in malaria parasites; possible drug targets." Brightsurf News, Aug. 4 2010, https://www.brightsurf.com/news/L5579QXL/nih-grantees-find-metabolic-pathway-in-malaria-parasites-possible-drug-targets.html.